Team:Arizona State

From 2013.igem.org

(Difference between revisions)
Line 39: Line 39:
<center><div class="fb-like" data-href="https://www.facebook.com/pages/ASU-iGEM/196387053746045?fref=ts" data-send="true" data-width="450" data-show-faces="false"></div></center>
<center><div class="fb-like" data-href="https://www.facebook.com/pages/ASU-iGEM/196387053746045?fref=ts" data-send="true" data-width="450" data-show-faces="false"></div></center>
-
 
-
<br>
 
-
 
-
<a class="twitter-timeline" href="https://twitter.com/asuigem" data-widget-id="331125961636585473">Tweets by @asuigem</a>
 
-
<script>!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+"://platform.twitter.com/widgets.js";fjs.parentNode.insertBefore(js,fjs);}}(document,"script","twitter-wjs");</script>
 
</body>
</body>
</html>
</html>

Revision as of 16:07, 5 September 2013

Home Team Official Team Profile Project Parts Submitted to the Registry Modeling Notebook Safety Attributions

Cancer kills eight million people each year. Current treatments involve therapies such as chemotherapy and radiation that cannot differentiate between cancerous and healthy tissue. The ASU iGEM team proposes a novel vaccine delivery system of tumor-specific proteins and other elements to mitigate the anti-immune response of tumor cells, all encapsulated within probiotic bacteria, akin to those found in commercial yogurt. The vaccine should activate immune cells to teach a patient’s immune system to detect specific markers that distinguish tumors from healthy tissue and destroy the tumor cells.